In last trading session, Bright Minds Biosciences Inc (NASDAQ:DRUG) saw 26.96 million shares changing hands with its beta currently measuring 1.91. Company’s recent per share price level of $47.21 trading at $25.51 or 117.56% at ring of the bell on the day assigns it a market valuation of $210.56M. That closing price of DRUG’s stock is at a premium of 18.47% from its 52-week high price of $38.49 and is indicating a premium of 98.03% from its 52-week low price of $0.93. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 14.05 million shares which gives us an average trading volume of 2.26 million if we extend that period to 3-months.
Bright Minds Biosciences Inc (NASDAQ:DRUG) trade information
Upright in the green during last session for gaining 117.56%, in the last five days DRUG remained trading in the green while hitting it’s week-highest on Friday, 10/18/24 when the stock touched $47.21 price level, adding 40.26% to its value on the day. Bright Minds Biosciences Inc’s shares saw a change of 3201.40% in year-to-date performance and have moved 4271.70% in past 5-day. Bright Minds Biosciences Inc (NASDAQ:DRUG) showed a performance of 3695.93% in past 30-days. Number of shares sold short was 85132.0 shares which calculate 3.5 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bright Minds Biosciences Inc (DRUG) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -137.36% during past 5 years.
Bright Minds Biosciences Inc (NASDAQ:DRUG)’s Major holders
Insiders are in possession of 31.00% of company’s total shares while institution are holding 4.42 percent of that, with stock having share float percentage of 6.41%. Investors also watch the number of corporate investors in a company very closely, which is 4.42% institutions for Bright Minds Biosciences Inc that are currently holding shares of the company.
